AI predicts who will survive lung failure after turning therapy
NCT ID NCT07445061
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This study looks at 377 adults with severe lung failure (ARDS) who were treated with prone positioning (lying face down to help breathing). Researchers will use computer models to predict which patients are at highest risk of dying in the ICU. The goal is to help doctors make better treatment decisions for each patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
358 people
The number who actually took part.
- Started
-
Mar 2026
- Finished
-
May 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients diagnosed with acute respiratory distress syndrome (ARDS) who received prone position ventilation in the intensive care unit at Zhongshan Hospital, Fudan University, between October 2019 and August 2025. Clinical data were retrospectively obtained from electronic medical records.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of ARDS according to the Berlin definition; * Receipt of at least one session of prone position ventilation (PPV) during hospitalization; * Requirement for mechanical ventilation. Exclusion Criteria: * Age \<18 years; * PPV duration \<6 hours; * ICU length of stay \<2 days; * Pregnancy; * Receipt of awake prone positioning. * Missing key clinical data.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute respiratory distress syndrome (ARDS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI that refreshes ICU death risk every 6 hours put to the test
- Can a peptide drug shield the hearts of ICU patients?
- Is thicker blood a hidden player in ARDS?
- Can a wrist sensor cut the dose of ICU muscle relaxants?
- Predictive model may personalize ICU feeding to cut intolerance
- AI reads heart ultrasound at the bedside: a test for faster detection of weak heart pumping